Menarini Biotech
Nicola Torre is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as General Manager at Menarini Biotech since June 2023, focusing on biologics contract development and manufacturing. Prior experience includes roles as Site Director at Centrient Pharmaceuticals, Industrial Site Head at ITALFARMACO S.P.A., and president of the manufacturing platform at Zoetis, where managerial responsibilities spanned multiple sites and legal entities. Torre also held significant positions at Patheon, DSM, and Novartis, driving operations and new business development in various capacities, including leadership in manufacturing technologies, process improvements, and strategic direction. Educational credentials include a degree in Industrial Biotechnology from Università degli Studi di Napoli Federico II.
This person is not in any teams
Menarini Biotech
4 followers
Menarini Biotech (“MBH”) is a fast-growing, agile, fully integrated CDMO for biologics located in the greater Rome area, Italy. Established in 2003, Menarini Biotech’s mission is to provide fast and efficient, yet very customer-centric, world-class, high-quality, services for biotech companies from preclinical development to GMP manufacturing (Mammalian and Microbial) up to BSL-2. These include CHO cell line development and analytical development for standard and non-standard mAbs, and new molecular formats, e.g. bispecifics, ADCs, fusion proteins. Our Quality System complies with AIFA/EU GMP requirements.